Examination of a New Non Invasive Sensor "Lifebeam" During HTT in Protective Clothing
NCT ID: NCT01789931
Last Updated: 2014-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2014-12-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Sensor for Core Temperature Measurement
NCT02017184
Measuring Core Body Temperature Using a Novel Non-invasive Sensor
NCT02691832
Temperature Measurement Using a Non Invasive Device
NCT01584401
The Development Of A Novel Biomarker For Early Identification Of The Individual's State Of Tolerance To Heat
NCT01290159
The Effect of Ventilated Vest on Thermoregulation During Exercise in Hot Environment
NCT01863927
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Research arm
The participants will undergo an examination day in which they will complete VO2max test to evaluate their aerobic fitness. Afterwards they'll undergo 3 heat tolerance test (HTT) days: without CB protective clothing, with CB protective clothing, and with work clothes. During the tests, a "Lifebeam" sensor will be attached to their skin.
"Lifebeam"
The "lifebeam" sensor will be attached to the participant's skin during the HTT.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"Lifebeam"
The "lifebeam" sensor will be attached to the participant's skin during the HTT.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy
* after medical checkup
* after signing concent form
Exclusion Criteria
* respiratory disease
* baseline bp above 140/90 mmHg
* sleep disorders
* diabetes
* anhydrosis
* skin disease
* acute illness in last 3 days prior to the examination
21 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Barliz Adato
head investigator of Heller institute of physiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barliz Adato, MD
Role: PRINCIPAL_INVESTIGATOR
Heller institute, Sheba medical center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheba medical center
Tel-Hashomer, Ramat- Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-12-9435-BA-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.